Nadifloxacin

CAS: 124858-35-1

Ref. 3D-AF26117

Produktinformation

• Name: Nadifloxacin
• Synonyme: 9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acidJinofloxacinOPC-7251, (±)-9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic Acid, 124858-35-1, 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, 9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid, Jinofloxacin, Nadibact, Nadixa, Opc 7251

Beschreibung

Nadifloxacin is an antimicrobial agent of the fluoroquinolone class that has been shown to be effective against drug-resistant strains, such as tetracycline-resistant strains. Nadifloxacin binds to the DNA gyrase and topoisomerase IV enzymes, which are necessary for bacterial DNA synthesis and cell division. It has been shown to be active against some wild-type strains and resistant mutant strains of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Nadifloxacin may interact with other drugs by increasing their concentration in human serum or compete with other drugs for binding sites on odorant receptors in the nose.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 360.38 g/mol
• Formel: C₁₉H₂₁FN₂O₄
• Reinheit: Min. 95%
• Farbe/Form: White Powder
• InChl: InChI=1S/C19H21FN2O4/c1-10-2-3-12-16-13(18(24)14(19(25)26)9-22(10)16)8-15(20)17(12)21-6-4-11(23)5-7-21/h8-11,23H,2-7H2,1H3,(H,25,26)
• InChI Key: InChIKey=JYJTVFIEFKZWCJ-UHFFFAOYSA-N
• SMILES: CC1CCc2c(N3CCC(O)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23